Global Matuzumab Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Medical Vacuum Regulator market size is predicted to grow from US$ 166 million in 2025 to US$ 235 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
Medical Vacuum Regulator is a medical device that converts the high-pressure vacuum that is supplied by the hospitals central vacuum system to a safe level for use on a patient.
The vacuum regulator is used to measure and adjust the vacuum level within the context of medical suction. It enables to drain substances out of the patient’s body during surgical procedures. The vacuum regulator should be connected to a vacuum source on the wall either using a direct probe or a rail mounting system. It should be associated with a collection jar and a suction hose.
Global Medical Vacuum Regulator key players include Ohio Medical, Amico, Precision Medical, Air Liquid Healthcare, Integral, etc. Global top five manufacturers hold a share about 35%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, having a total share about 55 percent.
In terms of product, Analog Vacuum Regulator is the largest segment, with a share about 70%. And in terms of application, the largest application is in Clinical, followed by Surgical.
LP Information, Inc. (LPI) ' newest research report, the “Medical Vacuum Regulator Industry Forecast” looks at past sales and reviews total world Medical Vacuum Regulator sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Vacuum Regulator sales for 2025 through 2031. With Medical Vacuum Regulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Vacuum Regulator industry.
This Insight Report provides a comprehensive analysis of the global Medical Vacuum Regulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Vacuum Regulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Vacuum Regulator market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Vacuum Regulator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Vacuum Regulator.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Vacuum Regulator market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Medical Vacuum Regulator market?
What factors are driving Medical Vacuum Regulator market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Vacuum Regulator market opportunities vary by end market size?
How does Medical Vacuum Regulator break out by Type, by Application?
The global Medical Vacuum Regulator market size is predicted to grow from US$ 166 million in 2025 to US$ 235 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
Medical Vacuum Regulator is a medical device that converts the high-pressure vacuum that is supplied by the hospitals central vacuum system to a safe level for use on a patient.
The vacuum regulator is used to measure and adjust the vacuum level within the context of medical suction. It enables to drain substances out of the patient’s body during surgical procedures. The vacuum regulator should be connected to a vacuum source on the wall either using a direct probe or a rail mounting system. It should be associated with a collection jar and a suction hose.
Global Medical Vacuum Regulator key players include Ohio Medical, Amico, Precision Medical, Air Liquid Healthcare, Integral, etc. Global top five manufacturers hold a share about 35%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, having a total share about 55 percent.
In terms of product, Analog Vacuum Regulator is the largest segment, with a share about 70%. And in terms of application, the largest application is in Clinical, followed by Surgical.
LP Information, Inc. (LPI) ' newest research report, the “Medical Vacuum Regulator Industry Forecast” looks at past sales and reviews total world Medical Vacuum Regulator sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Vacuum Regulator sales for 2025 through 2031. With Medical Vacuum Regulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Vacuum Regulator industry.
This Insight Report provides a comprehensive analysis of the global Medical Vacuum Regulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Vacuum Regulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Vacuum Regulator market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Vacuum Regulator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Vacuum Regulator.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Vacuum Regulator market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Analog Vacuum Regulator
- Digital Vacuum Regulator
- Clinically
- Surgical
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ohio Medical
- Amico
- Precision Medical
- Air Liquid Healthcare
- Integral
- Allied Healthcare Products
- Shanghai Amcaremed Technology
- Acare
- Hersill
What is the 10-year outlook for the global Medical Vacuum Regulator market?
What factors are driving Medical Vacuum Regulator market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Vacuum Regulator market opportunities vary by end market size?
How does Medical Vacuum Regulator break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Matuzumab Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Matuzumab by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Matuzumab by Country/Region, 2020, 2024 & 2031
2.2 Matuzumab Segment by Type
2.2.1 Patent
2.2.2 Generic
2.3 Matuzumab Sales by Type
2.3.1 Global Matuzumab Sales Market Share by Type (2020-2025)
2.3.2 Global Matuzumab Revenue and Market Share by Type (2020-2025)
2.3.3 Global Matuzumab Sale Price by Type (2020-2025)
2.4 Matuzumab Segment by Application
2.4.1 Chemical
2.4.2 Pharmaceutical
2.5 Matuzumab Sales by Application
2.5.1 Global Matuzumab Sale Market Share by Application (2020-2025)
2.5.2 Global Matuzumab Revenue and Market Share by Application (2020-2025)
2.5.3 Global Matuzumab Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Matuzumab Breakdown Data by Company
3.1.1 Global Matuzumab Annual Sales by Company (2020-2025)
3.1.2 Global Matuzumab Sales Market Share by Company (2020-2025)
3.2 Global Matuzumab Annual Revenue by Company (2020-2025)
3.2.1 Global Matuzumab Revenue by Company (2020-2025)
3.2.2 Global Matuzumab Revenue Market Share by Company (2020-2025)
3.3 Global Matuzumab Sale Price by Company
3.4 Key Manufacturers Matuzumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Matuzumab Product Location Distribution
3.4.2 Players Matuzumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MATUZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Matuzumab Market Size by Geographic Region (2020-2025)
4.1.1 Global Matuzumab Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Matuzumab Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Matuzumab Market Size by Country/Region (2020-2025)
4.2.1 Global Matuzumab Annual Sales by Country/Region (2020-2025)
4.2.2 Global Matuzumab Annual Revenue by Country/Region (2020-2025)
4.3 Americas Matuzumab Sales Growth
4.4 APAC Matuzumab Sales Growth
4.5 Europe Matuzumab Sales Growth
4.6 Middle East & Africa Matuzumab Sales Growth
5 AMERICAS
5.1 Americas Matuzumab Sales by Country
5.1.1 Americas Matuzumab Sales by Country (2020-2025)
5.1.2 Americas Matuzumab Revenue by Country (2020-2025)
5.2 Americas Matuzumab Sales by Type (2020-2025)
5.3 Americas Matuzumab Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Matuzumab Sales by Region
6.1.1 APAC Matuzumab Sales by Region (2020-2025)
6.1.2 APAC Matuzumab Revenue by Region (2020-2025)
6.2 APAC Matuzumab Sales by Type (2020-2025)
6.3 APAC Matuzumab Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Matuzumab by Country
7.1.1 Europe Matuzumab Sales by Country (2020-2025)
7.1.2 Europe Matuzumab Revenue by Country (2020-2025)
7.2 Europe Matuzumab Sales by Type (2020-2025)
7.3 Europe Matuzumab Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Matuzumab by Country
8.1.1 Middle East & Africa Matuzumab Sales by Country (2020-2025)
8.1.2 Middle East & Africa Matuzumab Revenue by Country (2020-2025)
8.2 Middle East & Africa Matuzumab Sales by Type (2020-2025)
8.3 Middle East & Africa Matuzumab Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Matuzumab
10.3 Manufacturing Process Analysis of Matuzumab
10.4 Industry Chain Structure of Matuzumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Matuzumab Distributors
11.3 Matuzumab Customer
12 WORLD FORECAST REVIEW FOR MATUZUMAB BY GEOGRAPHIC REGION
12.1 Global Matuzumab Market Size Forecast by Region
12.1.1 Global Matuzumab Forecast by Region (2026-2031)
12.1.2 Global Matuzumab Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Matuzumab Forecast by Type (2026-2031)
12.7 Global Matuzumab Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Biosynth Carbosynth
13.1.1 Biosynth Carbosynth Company Information
13.1.2 Biosynth Carbosynth Matuzumab Product Portfolios and Specifications
13.1.3 Biosynth Carbosynth Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Biosynth Carbosynth Main Business Overview
13.1.5 Biosynth Carbosynth Latest Developments
13.2 BOC Sciences
13.2.1 BOC Sciences Company Information
13.2.2 BOC Sciences Matuzumab Product Portfolios and Specifications
13.2.3 BOC Sciences Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 BOC Sciences Main Business Overview
13.2.5 BOC Sciences Latest Developments
13.3 Carbosynth
13.3.1 Carbosynth Company Information
13.3.2 Carbosynth Matuzumab Product Portfolios and Specifications
13.3.3 Carbosynth Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Carbosynth Main Business Overview
13.3.5 Carbosynth Latest Developments
13.4 Merck KGaA
13.4.1 Merck KGaA Company Information
13.4.2 Merck KGaA Matuzumab Product Portfolios and Specifications
13.4.3 Merck KGaA Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck KGaA Main Business Overview
13.4.5 Merck KGaA Latest Developments
13.5 Shanghai Yifei Biotechnology
13.5.1 Shanghai Yifei Biotechnology Company Information
13.5.2 Shanghai Yifei Biotechnology Matuzumab Product Portfolios and Specifications
13.5.3 Shanghai Yifei Biotechnology Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Shanghai Yifei Biotechnology Main Business Overview
13.5.5 Shanghai Yifei Biotechnology Latest Developments
13.6 Takeda Pharmaceutical
13.6.1 Takeda Pharmaceutical Company Information
13.6.2 Takeda Pharmaceutical Matuzumab Product Portfolios and Specifications
13.6.3 Takeda Pharmaceutical Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Takeda Pharmaceutical Main Business Overview
13.6.5 Takeda Pharmaceutical Latest Developments
13.7 TargetMol Chemicals
13.7.1 TargetMol Chemicals Company Information
13.7.2 TargetMol Chemicals Matuzumab Product Portfolios and Specifications
13.7.3 TargetMol Chemicals Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 TargetMol Chemicals Main Business Overview
13.7.5 TargetMol Chemicals Latest Developments
13.8 Wonda Science
13.8.1 Wonda Science Company Information
13.8.2 Wonda Science Matuzumab Product Portfolios and Specifications
13.8.3 Wonda Science Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Wonda Science Main Business Overview
13.8.5 Wonda Science Latest Developments
13.9 Hangzhou Dayangchem
13.9.1 Hangzhou Dayangchem Company Information
13.9.2 Hangzhou Dayangchem Matuzumab Product Portfolios and Specifications
13.9.3 Hangzhou Dayangchem Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Hangzhou Dayangchem Main Business Overview
13.9.5 Hangzhou Dayangchem Latest Developments
13.10 Leap Chem
13.10.1 Leap Chem Company Information
13.10.2 Leap Chem Matuzumab Product Portfolios and Specifications
13.10.3 Leap Chem Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Leap Chem Main Business Overview
13.10.5 Leap Chem Latest Developments
13.11 Nantong Feiyu Biological Technology
13.11.1 Nantong Feiyu Biological Technology Company Information
13.11.2 Nantong Feiyu Biological Technology Matuzumab Product Portfolios and Specifications
13.11.3 Nantong Feiyu Biological Technology Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Nantong Feiyu Biological Technology Main Business Overview
13.11.5 Nantong Feiyu Biological Technology Latest Developments
13.12 Ningbo Inno Pharmchem
13.12.1 Ningbo Inno Pharmchem Company Information
13.12.2 Ningbo Inno Pharmchem Matuzumab Product Portfolios and Specifications
13.12.3 Ningbo Inno Pharmchem Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Ningbo Inno Pharmchem Main Business Overview
13.12.5 Ningbo Inno Pharmchem Latest Developments
13.13 Sichuan Weiqi Biotechnology
13.13.1 Sichuan Weiqi Biotechnology Company Information
13.13.2 Sichuan Weiqi Biotechnology Matuzumab Product Portfolios and Specifications
13.13.3 Sichuan Weiqi Biotechnology Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Sichuan Weiqi Biotechnology Main Business Overview
13.13.5 Sichuan Weiqi Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Matuzumab Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Matuzumab by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Matuzumab by Country/Region, 2020, 2024 & 2031
2.2 Matuzumab Segment by Type
2.2.1 Patent
2.2.2 Generic
2.3 Matuzumab Sales by Type
2.3.1 Global Matuzumab Sales Market Share by Type (2020-2025)
2.3.2 Global Matuzumab Revenue and Market Share by Type (2020-2025)
2.3.3 Global Matuzumab Sale Price by Type (2020-2025)
2.4 Matuzumab Segment by Application
2.4.1 Chemical
2.4.2 Pharmaceutical
2.5 Matuzumab Sales by Application
2.5.1 Global Matuzumab Sale Market Share by Application (2020-2025)
2.5.2 Global Matuzumab Revenue and Market Share by Application (2020-2025)
2.5.3 Global Matuzumab Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Matuzumab Breakdown Data by Company
3.1.1 Global Matuzumab Annual Sales by Company (2020-2025)
3.1.2 Global Matuzumab Sales Market Share by Company (2020-2025)
3.2 Global Matuzumab Annual Revenue by Company (2020-2025)
3.2.1 Global Matuzumab Revenue by Company (2020-2025)
3.2.2 Global Matuzumab Revenue Market Share by Company (2020-2025)
3.3 Global Matuzumab Sale Price by Company
3.4 Key Manufacturers Matuzumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Matuzumab Product Location Distribution
3.4.2 Players Matuzumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MATUZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Matuzumab Market Size by Geographic Region (2020-2025)
4.1.1 Global Matuzumab Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Matuzumab Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Matuzumab Market Size by Country/Region (2020-2025)
4.2.1 Global Matuzumab Annual Sales by Country/Region (2020-2025)
4.2.2 Global Matuzumab Annual Revenue by Country/Region (2020-2025)
4.3 Americas Matuzumab Sales Growth
4.4 APAC Matuzumab Sales Growth
4.5 Europe Matuzumab Sales Growth
4.6 Middle East & Africa Matuzumab Sales Growth
5 AMERICAS
5.1 Americas Matuzumab Sales by Country
5.1.1 Americas Matuzumab Sales by Country (2020-2025)
5.1.2 Americas Matuzumab Revenue by Country (2020-2025)
5.2 Americas Matuzumab Sales by Type (2020-2025)
5.3 Americas Matuzumab Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Matuzumab Sales by Region
6.1.1 APAC Matuzumab Sales by Region (2020-2025)
6.1.2 APAC Matuzumab Revenue by Region (2020-2025)
6.2 APAC Matuzumab Sales by Type (2020-2025)
6.3 APAC Matuzumab Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Matuzumab by Country
7.1.1 Europe Matuzumab Sales by Country (2020-2025)
7.1.2 Europe Matuzumab Revenue by Country (2020-2025)
7.2 Europe Matuzumab Sales by Type (2020-2025)
7.3 Europe Matuzumab Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Matuzumab by Country
8.1.1 Middle East & Africa Matuzumab Sales by Country (2020-2025)
8.1.2 Middle East & Africa Matuzumab Revenue by Country (2020-2025)
8.2 Middle East & Africa Matuzumab Sales by Type (2020-2025)
8.3 Middle East & Africa Matuzumab Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Matuzumab
10.3 Manufacturing Process Analysis of Matuzumab
10.4 Industry Chain Structure of Matuzumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Matuzumab Distributors
11.3 Matuzumab Customer
12 WORLD FORECAST REVIEW FOR MATUZUMAB BY GEOGRAPHIC REGION
12.1 Global Matuzumab Market Size Forecast by Region
12.1.1 Global Matuzumab Forecast by Region (2026-2031)
12.1.2 Global Matuzumab Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Matuzumab Forecast by Type (2026-2031)
12.7 Global Matuzumab Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Biosynth Carbosynth
13.1.1 Biosynth Carbosynth Company Information
13.1.2 Biosynth Carbosynth Matuzumab Product Portfolios and Specifications
13.1.3 Biosynth Carbosynth Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Biosynth Carbosynth Main Business Overview
13.1.5 Biosynth Carbosynth Latest Developments
13.2 BOC Sciences
13.2.1 BOC Sciences Company Information
13.2.2 BOC Sciences Matuzumab Product Portfolios and Specifications
13.2.3 BOC Sciences Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 BOC Sciences Main Business Overview
13.2.5 BOC Sciences Latest Developments
13.3 Carbosynth
13.3.1 Carbosynth Company Information
13.3.2 Carbosynth Matuzumab Product Portfolios and Specifications
13.3.3 Carbosynth Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Carbosynth Main Business Overview
13.3.5 Carbosynth Latest Developments
13.4 Merck KGaA
13.4.1 Merck KGaA Company Information
13.4.2 Merck KGaA Matuzumab Product Portfolios and Specifications
13.4.3 Merck KGaA Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck KGaA Main Business Overview
13.4.5 Merck KGaA Latest Developments
13.5 Shanghai Yifei Biotechnology
13.5.1 Shanghai Yifei Biotechnology Company Information
13.5.2 Shanghai Yifei Biotechnology Matuzumab Product Portfolios and Specifications
13.5.3 Shanghai Yifei Biotechnology Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Shanghai Yifei Biotechnology Main Business Overview
13.5.5 Shanghai Yifei Biotechnology Latest Developments
13.6 Takeda Pharmaceutical
13.6.1 Takeda Pharmaceutical Company Information
13.6.2 Takeda Pharmaceutical Matuzumab Product Portfolios and Specifications
13.6.3 Takeda Pharmaceutical Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Takeda Pharmaceutical Main Business Overview
13.6.5 Takeda Pharmaceutical Latest Developments
13.7 TargetMol Chemicals
13.7.1 TargetMol Chemicals Company Information
13.7.2 TargetMol Chemicals Matuzumab Product Portfolios and Specifications
13.7.3 TargetMol Chemicals Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 TargetMol Chemicals Main Business Overview
13.7.5 TargetMol Chemicals Latest Developments
13.8 Wonda Science
13.8.1 Wonda Science Company Information
13.8.2 Wonda Science Matuzumab Product Portfolios and Specifications
13.8.3 Wonda Science Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Wonda Science Main Business Overview
13.8.5 Wonda Science Latest Developments
13.9 Hangzhou Dayangchem
13.9.1 Hangzhou Dayangchem Company Information
13.9.2 Hangzhou Dayangchem Matuzumab Product Portfolios and Specifications
13.9.3 Hangzhou Dayangchem Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Hangzhou Dayangchem Main Business Overview
13.9.5 Hangzhou Dayangchem Latest Developments
13.10 Leap Chem
13.10.1 Leap Chem Company Information
13.10.2 Leap Chem Matuzumab Product Portfolios and Specifications
13.10.3 Leap Chem Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Leap Chem Main Business Overview
13.10.5 Leap Chem Latest Developments
13.11 Nantong Feiyu Biological Technology
13.11.1 Nantong Feiyu Biological Technology Company Information
13.11.2 Nantong Feiyu Biological Technology Matuzumab Product Portfolios and Specifications
13.11.3 Nantong Feiyu Biological Technology Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Nantong Feiyu Biological Technology Main Business Overview
13.11.5 Nantong Feiyu Biological Technology Latest Developments
13.12 Ningbo Inno Pharmchem
13.12.1 Ningbo Inno Pharmchem Company Information
13.12.2 Ningbo Inno Pharmchem Matuzumab Product Portfolios and Specifications
13.12.3 Ningbo Inno Pharmchem Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Ningbo Inno Pharmchem Main Business Overview
13.12.5 Ningbo Inno Pharmchem Latest Developments
13.13 Sichuan Weiqi Biotechnology
13.13.1 Sichuan Weiqi Biotechnology Company Information
13.13.2 Sichuan Weiqi Biotechnology Matuzumab Product Portfolios and Specifications
13.13.3 Sichuan Weiqi Biotechnology Matuzumab Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Sichuan Weiqi Biotechnology Main Business Overview
13.13.5 Sichuan Weiqi Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Matuzumab Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Matuzumab Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Patent
Table 4. Major Players of Generic
Table 5. Global Matuzumab Sales by Type (2020-2025) & (Kg)
Table 6. Global Matuzumab Sales Market Share by Type (2020-2025)
Table 7. Global Matuzumab Revenue by Type (2020-2025) & ($ million)
Table 8. Global Matuzumab Revenue Market Share by Type (2020-2025)
Table 9. Global Matuzumab Sale Price by Type (2020-2025) & (US$/Kg)
Table 10. Global Matuzumab Sale by Application (2020-2025) & (Kg)
Table 11. Global Matuzumab Sale Market Share by Application (2020-2025)
Table 12. Global Matuzumab Revenue by Application (2020-2025) & ($ million)
Table 13. Global Matuzumab Revenue Market Share by Application (2020-2025)
Table 14. Global Matuzumab Sale Price by Application (2020-2025) & (US$/Kg)
Table 15. Global Matuzumab Sales by Company (2020-2025) & (Kg)
Table 16. Global Matuzumab Sales Market Share by Company (2020-2025)
Table 17. Global Matuzumab Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Matuzumab Revenue Market Share by Company (2020-2025)
Table 19. Global Matuzumab Sale Price by Company (2020-2025) & (US$/Kg)
Table 20. Key Manufacturers Matuzumab Producing Area Distribution and Sales Area
Table 21. Players Matuzumab Products Offered
Table 22. Matuzumab Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Matuzumab Sales by Geographic Region (2020-2025) & (Kg)
Table 26. Global Matuzumab Sales Market Share Geographic Region (2020-2025)
Table 27. Global Matuzumab Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Matuzumab Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Matuzumab Sales by Country/Region (2020-2025) & (Kg)
Table 30. Global Matuzumab Sales Market Share by Country/Region (2020-2025)
Table 31. Global Matuzumab Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Matuzumab Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Matuzumab Sales by Country (2020-2025) & (Kg)
Table 34. Americas Matuzumab Sales Market Share by Country (2020-2025)
Table 35. Americas Matuzumab Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Matuzumab Sales by Type (2020-2025) & (Kg)
Table 37. Americas Matuzumab Sales by Application (2020-2025) & (Kg)
Table 38. APAC Matuzumab Sales by Region (2020-2025) & (Kg)
Table 39. APAC Matuzumab Sales Market Share by Region (2020-2025)
Table 40. APAC Matuzumab Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Matuzumab Sales by Type (2020-2025) & (Kg)
Table 42. APAC Matuzumab Sales by Application (2020-2025) & (Kg)
Table 43. Europe Matuzumab Sales by Country (2020-2025) & (Kg)
Table 44. Europe Matuzumab Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Matuzumab Sales by Type (2020-2025) & (Kg)
Table 46. Europe Matuzumab Sales by Application (2020-2025) & (Kg)
Table 47. Middle East & Africa Matuzumab Sales by Country (2020-2025) & (Kg)
Table 48. Middle East & Africa Matuzumab Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Matuzumab Sales by Type (2020-2025) & (Kg)
Table 50. Middle East & Africa Matuzumab Sales by Application (2020-2025) & (Kg)
Table 51. Key Market Drivers & Growth Opportunities of Matuzumab
Table 52. Key Market Challenges & Risks of Matuzumab
Table 53. Key Industry Trends of Matuzumab
Table 54. Matuzumab Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Matuzumab Distributors List
Table 57. Matuzumab Customer List
Table 58. Global Matuzumab Sales Forecast by Region (2026-2031) & (Kg)
Table 59. Global Matuzumab Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Matuzumab Sales Forecast by Country (2026-2031) & (Kg)
Table 61. Americas Matuzumab Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Matuzumab Sales Forecast by Region (2026-2031) & (Kg)
Table 63. APAC Matuzumab Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Matuzumab Sales Forecast by Country (2026-2031) & (Kg)
Table 65. Europe Matuzumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Matuzumab Sales Forecast by Country (2026-2031) & (Kg)
Table 67. Middle East & Africa Matuzumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Matuzumab Sales Forecast by Type (2026-2031) & (Kg)
Table 69. Global Matuzumab Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Matuzumab Sales Forecast by Application (2026-2031) & (Kg)
Table 71. Global Matuzumab Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Biosynth Carbosynth Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 73. Biosynth Carbosynth Matuzumab Product Portfolios and Specifications
Table 74. Biosynth Carbosynth Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 75. Biosynth Carbosynth Main Business
Table 76. Biosynth Carbosynth Latest Developments
Table 77. BOC Sciences Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 78. BOC Sciences Matuzumab Product Portfolios and Specifications
Table 79. BOC Sciences Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 80. BOC Sciences Main Business
Table 81. BOC Sciences Latest Developments
Table 82. Carbosynth Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 83. Carbosynth Matuzumab Product Portfolios and Specifications
Table 84. Carbosynth Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 85. Carbosynth Main Business
Table 86. Carbosynth Latest Developments
Table 87. Merck KGaA Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck KGaA Matuzumab Product Portfolios and Specifications
Table 89. Merck KGaA Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 90. Merck KGaA Main Business
Table 91. Merck KGaA Latest Developments
Table 92. Shanghai Yifei Biotechnology Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 93. Shanghai Yifei Biotechnology Matuzumab Product Portfolios and Specifications
Table 94. Shanghai Yifei Biotechnology Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 95. Shanghai Yifei Biotechnology Main Business
Table 96. Shanghai Yifei Biotechnology Latest Developments
Table 97.Takeda Pharmaceutical Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 98.Takeda Pharmaceutical Matuzumab Product Portfolios and Specifications
Table 99.Takeda Pharmaceutical Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 100.Takeda Pharmaceutical Main Business
Table 101.Takeda Pharmaceutical Latest Developments
Table 102.TargetMol Chemicals Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 103.TargetMol Chemicals Matuzumab Product Portfolios and Specifications
Table 104.TargetMol Chemicals Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 105.TargetMol Chemicals Main Business
Table 106.TargetMol Chemicals Latest Developments
Table 107. Wonda Science Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 108. Wonda Science Matuzumab Product Portfolios and Specifications
Table 109. Wonda Science Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 110. Wonda Science Main Business
Table 111. Wonda Science Latest Developments
Table 112. Hangzhou Dayangchem Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 113. Hangzhou Dayangchem Matuzumab Product Portfolios and Specifications
Table 114. Hangzhou Dayangchem Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 115. Hangzhou Dayangchem Main Business
Table 116. Hangzhou Dayangchem Latest Developments
Table 117. Leap Chem Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 118. Leap Chem Matuzumab Product Portfolios and Specifications
Table 119. Leap Chem Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 120. Leap Chem Main Business
Table 121. Leap Chem Latest Developments
Table 122. Nantong Feiyu Biological Technology Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 123. Nantong Feiyu Biological Technology Matuzumab Product Portfolios and Specifications
Table 124. Nantong Feiyu Biological Technology Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 125. Nantong Feiyu Biological Technology Main Business
Table 126. Nantong Feiyu Biological Technology Latest Developments
Table 127. Ningbo Inno Pharmchem Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 128. Ningbo Inno Pharmchem Matuzumab Product Portfolios and Specifications
Table 129. Ningbo Inno Pharmchem Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 130. Ningbo Inno Pharmchem Main Business
Table 131. Ningbo Inno Pharmchem Latest Developments
Table 132. Sichuan Weiqi Biotechnology Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 133. Sichuan Weiqi Biotechnology Matuzumab Product Portfolios and Specifications
Table 134. Sichuan Weiqi Biotechnology Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 135. Sichuan Weiqi Biotechnology Main Business
Table 136. Sichuan Weiqi Biotechnology Latest Developments
Table 1. Matuzumab Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Matuzumab Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Patent
Table 4. Major Players of Generic
Table 5. Global Matuzumab Sales by Type (2020-2025) & (Kg)
Table 6. Global Matuzumab Sales Market Share by Type (2020-2025)
Table 7. Global Matuzumab Revenue by Type (2020-2025) & ($ million)
Table 8. Global Matuzumab Revenue Market Share by Type (2020-2025)
Table 9. Global Matuzumab Sale Price by Type (2020-2025) & (US$/Kg)
Table 10. Global Matuzumab Sale by Application (2020-2025) & (Kg)
Table 11. Global Matuzumab Sale Market Share by Application (2020-2025)
Table 12. Global Matuzumab Revenue by Application (2020-2025) & ($ million)
Table 13. Global Matuzumab Revenue Market Share by Application (2020-2025)
Table 14. Global Matuzumab Sale Price by Application (2020-2025) & (US$/Kg)
Table 15. Global Matuzumab Sales by Company (2020-2025) & (Kg)
Table 16. Global Matuzumab Sales Market Share by Company (2020-2025)
Table 17. Global Matuzumab Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Matuzumab Revenue Market Share by Company (2020-2025)
Table 19. Global Matuzumab Sale Price by Company (2020-2025) & (US$/Kg)
Table 20. Key Manufacturers Matuzumab Producing Area Distribution and Sales Area
Table 21. Players Matuzumab Products Offered
Table 22. Matuzumab Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Matuzumab Sales by Geographic Region (2020-2025) & (Kg)
Table 26. Global Matuzumab Sales Market Share Geographic Region (2020-2025)
Table 27. Global Matuzumab Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Matuzumab Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Matuzumab Sales by Country/Region (2020-2025) & (Kg)
Table 30. Global Matuzumab Sales Market Share by Country/Region (2020-2025)
Table 31. Global Matuzumab Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Matuzumab Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Matuzumab Sales by Country (2020-2025) & (Kg)
Table 34. Americas Matuzumab Sales Market Share by Country (2020-2025)
Table 35. Americas Matuzumab Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Matuzumab Sales by Type (2020-2025) & (Kg)
Table 37. Americas Matuzumab Sales by Application (2020-2025) & (Kg)
Table 38. APAC Matuzumab Sales by Region (2020-2025) & (Kg)
Table 39. APAC Matuzumab Sales Market Share by Region (2020-2025)
Table 40. APAC Matuzumab Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Matuzumab Sales by Type (2020-2025) & (Kg)
Table 42. APAC Matuzumab Sales by Application (2020-2025) & (Kg)
Table 43. Europe Matuzumab Sales by Country (2020-2025) & (Kg)
Table 44. Europe Matuzumab Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Matuzumab Sales by Type (2020-2025) & (Kg)
Table 46. Europe Matuzumab Sales by Application (2020-2025) & (Kg)
Table 47. Middle East & Africa Matuzumab Sales by Country (2020-2025) & (Kg)
Table 48. Middle East & Africa Matuzumab Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Matuzumab Sales by Type (2020-2025) & (Kg)
Table 50. Middle East & Africa Matuzumab Sales by Application (2020-2025) & (Kg)
Table 51. Key Market Drivers & Growth Opportunities of Matuzumab
Table 52. Key Market Challenges & Risks of Matuzumab
Table 53. Key Industry Trends of Matuzumab
Table 54. Matuzumab Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Matuzumab Distributors List
Table 57. Matuzumab Customer List
Table 58. Global Matuzumab Sales Forecast by Region (2026-2031) & (Kg)
Table 59. Global Matuzumab Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Matuzumab Sales Forecast by Country (2026-2031) & (Kg)
Table 61. Americas Matuzumab Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Matuzumab Sales Forecast by Region (2026-2031) & (Kg)
Table 63. APAC Matuzumab Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Matuzumab Sales Forecast by Country (2026-2031) & (Kg)
Table 65. Europe Matuzumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Matuzumab Sales Forecast by Country (2026-2031) & (Kg)
Table 67. Middle East & Africa Matuzumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Matuzumab Sales Forecast by Type (2026-2031) & (Kg)
Table 69. Global Matuzumab Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Matuzumab Sales Forecast by Application (2026-2031) & (Kg)
Table 71. Global Matuzumab Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Biosynth Carbosynth Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 73. Biosynth Carbosynth Matuzumab Product Portfolios and Specifications
Table 74. Biosynth Carbosynth Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 75. Biosynth Carbosynth Main Business
Table 76. Biosynth Carbosynth Latest Developments
Table 77. BOC Sciences Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 78. BOC Sciences Matuzumab Product Portfolios and Specifications
Table 79. BOC Sciences Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 80. BOC Sciences Main Business
Table 81. BOC Sciences Latest Developments
Table 82. Carbosynth Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 83. Carbosynth Matuzumab Product Portfolios and Specifications
Table 84. Carbosynth Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 85. Carbosynth Main Business
Table 86. Carbosynth Latest Developments
Table 87. Merck KGaA Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck KGaA Matuzumab Product Portfolios and Specifications
Table 89. Merck KGaA Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 90. Merck KGaA Main Business
Table 91. Merck KGaA Latest Developments
Table 92. Shanghai Yifei Biotechnology Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 93. Shanghai Yifei Biotechnology Matuzumab Product Portfolios and Specifications
Table 94. Shanghai Yifei Biotechnology Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 95. Shanghai Yifei Biotechnology Main Business
Table 96. Shanghai Yifei Biotechnology Latest Developments
Table 97.Takeda Pharmaceutical Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 98.Takeda Pharmaceutical Matuzumab Product Portfolios and Specifications
Table 99.Takeda Pharmaceutical Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 100.Takeda Pharmaceutical Main Business
Table 101.Takeda Pharmaceutical Latest Developments
Table 102.TargetMol Chemicals Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 103.TargetMol Chemicals Matuzumab Product Portfolios and Specifications
Table 104.TargetMol Chemicals Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 105.TargetMol Chemicals Main Business
Table 106.TargetMol Chemicals Latest Developments
Table 107. Wonda Science Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 108. Wonda Science Matuzumab Product Portfolios and Specifications
Table 109. Wonda Science Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 110. Wonda Science Main Business
Table 111. Wonda Science Latest Developments
Table 112. Hangzhou Dayangchem Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 113. Hangzhou Dayangchem Matuzumab Product Portfolios and Specifications
Table 114. Hangzhou Dayangchem Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 115. Hangzhou Dayangchem Main Business
Table 116. Hangzhou Dayangchem Latest Developments
Table 117. Leap Chem Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 118. Leap Chem Matuzumab Product Portfolios and Specifications
Table 119. Leap Chem Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 120. Leap Chem Main Business
Table 121. Leap Chem Latest Developments
Table 122. Nantong Feiyu Biological Technology Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 123. Nantong Feiyu Biological Technology Matuzumab Product Portfolios and Specifications
Table 124. Nantong Feiyu Biological Technology Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 125. Nantong Feiyu Biological Technology Main Business
Table 126. Nantong Feiyu Biological Technology Latest Developments
Table 127. Ningbo Inno Pharmchem Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 128. Ningbo Inno Pharmchem Matuzumab Product Portfolios and Specifications
Table 129. Ningbo Inno Pharmchem Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 130. Ningbo Inno Pharmchem Main Business
Table 131. Ningbo Inno Pharmchem Latest Developments
Table 132. Sichuan Weiqi Biotechnology Basic Information, Matuzumab Manufacturing Base, Sales Area and Its Competitors
Table 133. Sichuan Weiqi Biotechnology Matuzumab Product Portfolios and Specifications
Table 134. Sichuan Weiqi Biotechnology Matuzumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 135. Sichuan Weiqi Biotechnology Main Business
Table 136. Sichuan Weiqi Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Matuzumab
Figure 2. Matuzumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Matuzumab Sales Growth Rate 2020-2031 (Kg)
Figure 7. Global Matuzumab Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Matuzumab Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Matuzumab Sales Market Share by Country/Region (2024)
Figure 10. Matuzumab Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Patent
Figure 12. Product Picture of Generic
Figure 13. Global Matuzumab Sales Market Share by Type in 2025
Figure 14. Global Matuzumab Revenue Market Share by Type (2020-2025)
Figure 15. Matuzumab Consumed in Chemical
Figure 16. Global Matuzumab Market: Chemical (2020-2025) & (Kg)
Figure 17. Matuzumab Consumed in Pharmaceutical
Figure 18. Global Matuzumab Market: Pharmaceutical (2020-2025) & (Kg)
Figure 19. Global Matuzumab Sale Market Share by Application (2024)
Figure 20. Global Matuzumab Revenue Market Share by Application in 2025
Figure 21. Matuzumab Sales by Company in 2025 (Kg)
Figure 22. Global Matuzumab Sales Market Share by Company in 2025
Figure 23. Matuzumab Revenue by Company in 2025 ($ millions)
Figure 24. Global Matuzumab Revenue Market Share by Company in 2025
Figure 25. Global Matuzumab Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Matuzumab Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Matuzumab Sales 2020-2025 (Kg)
Figure 28. Americas Matuzumab Revenue 2020-2025 ($ millions)
Figure 29. APAC Matuzumab Sales 2020-2025 (Kg)
Figure 30. APAC Matuzumab Revenue 2020-2025 ($ millions)
Figure 31. Europe Matuzumab Sales 2020-2025 (Kg)
Figure 32. Europe Matuzumab Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Matuzumab Sales 2020-2025 (Kg)
Figure 34. Middle East & Africa Matuzumab Revenue 2020-2025 ($ millions)
Figure 35. Americas Matuzumab Sales Market Share by Country in 2025
Figure 36. Americas Matuzumab Revenue Market Share by Country (2020-2025)
Figure 37. Americas Matuzumab Sales Market Share by Type (2020-2025)
Figure 38. Americas Matuzumab Sales Market Share by Application (2020-2025)
Figure 39. United States Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Matuzumab Sales Market Share by Region in 2025
Figure 44. APAC Matuzumab Revenue Market Share by Region (2020-2025)
Figure 45. APAC Matuzumab Sales Market Share by Type (2020-2025)
Figure 46. APAC Matuzumab Sales Market Share by Application (2020-2025)
Figure 47. China Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 51. India Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Matuzumab Sales Market Share by Country in 2025
Figure 55. Europe Matuzumab Revenue Market Share by Country (2020-2025)
Figure 56. Europe Matuzumab Sales Market Share by Type (2020-2025)
Figure 57. Europe Matuzumab Sales Market Share by Application (2020-2025)
Figure 58. Germany Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 59. France Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Matuzumab Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Matuzumab Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Matuzumab Sales Market Share by Application (2020-2025)
Figure 66. Egypt Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Matuzumab in 2025
Figure 72. Manufacturing Process Analysis of Matuzumab
Figure 73. Industry Chain Structure of Matuzumab
Figure 74. Channels of Distribution
Figure 75. Global Matuzumab Sales Market Forecast by Region (2026-2031)
Figure 76. Global Matuzumab Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Matuzumab Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Matuzumab Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Matuzumab Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Matuzumab Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Matuzumab
Figure 2. Matuzumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Matuzumab Sales Growth Rate 2020-2031 (Kg)
Figure 7. Global Matuzumab Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Matuzumab Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Matuzumab Sales Market Share by Country/Region (2024)
Figure 10. Matuzumab Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Patent
Figure 12. Product Picture of Generic
Figure 13. Global Matuzumab Sales Market Share by Type in 2025
Figure 14. Global Matuzumab Revenue Market Share by Type (2020-2025)
Figure 15. Matuzumab Consumed in Chemical
Figure 16. Global Matuzumab Market: Chemical (2020-2025) & (Kg)
Figure 17. Matuzumab Consumed in Pharmaceutical
Figure 18. Global Matuzumab Market: Pharmaceutical (2020-2025) & (Kg)
Figure 19. Global Matuzumab Sale Market Share by Application (2024)
Figure 20. Global Matuzumab Revenue Market Share by Application in 2025
Figure 21. Matuzumab Sales by Company in 2025 (Kg)
Figure 22. Global Matuzumab Sales Market Share by Company in 2025
Figure 23. Matuzumab Revenue by Company in 2025 ($ millions)
Figure 24. Global Matuzumab Revenue Market Share by Company in 2025
Figure 25. Global Matuzumab Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Matuzumab Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Matuzumab Sales 2020-2025 (Kg)
Figure 28. Americas Matuzumab Revenue 2020-2025 ($ millions)
Figure 29. APAC Matuzumab Sales 2020-2025 (Kg)
Figure 30. APAC Matuzumab Revenue 2020-2025 ($ millions)
Figure 31. Europe Matuzumab Sales 2020-2025 (Kg)
Figure 32. Europe Matuzumab Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Matuzumab Sales 2020-2025 (Kg)
Figure 34. Middle East & Africa Matuzumab Revenue 2020-2025 ($ millions)
Figure 35. Americas Matuzumab Sales Market Share by Country in 2025
Figure 36. Americas Matuzumab Revenue Market Share by Country (2020-2025)
Figure 37. Americas Matuzumab Sales Market Share by Type (2020-2025)
Figure 38. Americas Matuzumab Sales Market Share by Application (2020-2025)
Figure 39. United States Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Matuzumab Sales Market Share by Region in 2025
Figure 44. APAC Matuzumab Revenue Market Share by Region (2020-2025)
Figure 45. APAC Matuzumab Sales Market Share by Type (2020-2025)
Figure 46. APAC Matuzumab Sales Market Share by Application (2020-2025)
Figure 47. China Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 51. India Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Matuzumab Sales Market Share by Country in 2025
Figure 55. Europe Matuzumab Revenue Market Share by Country (2020-2025)
Figure 56. Europe Matuzumab Sales Market Share by Type (2020-2025)
Figure 57. Europe Matuzumab Sales Market Share by Application (2020-2025)
Figure 58. Germany Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 59. France Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Matuzumab Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Matuzumab Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Matuzumab Sales Market Share by Application (2020-2025)
Figure 66. Egypt Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Matuzumab Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Matuzumab in 2025
Figure 72. Manufacturing Process Analysis of Matuzumab
Figure 73. Industry Chain Structure of Matuzumab
Figure 74. Channels of Distribution
Figure 75. Global Matuzumab Sales Market Forecast by Region (2026-2031)
Figure 76. Global Matuzumab Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Matuzumab Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Matuzumab Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Matuzumab Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Matuzumab Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Enteral Tube Feeding Formula Market Growth 2025-2031
US$ 3,660.00
January 2024
95 pages
Global Electric Ion Beauty Instruments Market Growth 2024-2030
US$ 3,660.00
December 2023
110 pages
Global Medical Anesthesia Masks Market Growth 2024-2030
US$ 3,660.00
December 2024
121 pages
Global Brain Neurointerventional Device Market Growth 2025-2031
US$ 3,660.00
April 2025
141 pages
Global Healthcare Machine Vision System Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
86 pages
